CDT Equity Inc. files 8-K covering a debt obligation
The pharmaceutical company filed a Form 8-K on 2026-09-04 that includes debt and equity-related disclosure items.
CDT Equity Inc., a Delaware-incorporated pharmaceutical preparations company traded on Nasdaq under the tickers CDT and CDTTW, filed an 8-K on 2026-09-04 with accession number 0001493152-26-041533.[1][2]
The filing covers Items 1.01, 2.03, 3.02 and 9.01 and carries a period ending of 2026-08-31.[1]
The register records the filing under a debt obligation event for the company.[1]
Separately, the register lists an executive departure dated 2026-09-01 as a prior event for CDT Equity Inc.[3]